Rules in Progress

Pharmacy related email inbox: PharmacyRules@doh.wa.gov

Significant legislative rule-making process

CR-101 – Statement of Inquiry (Rules under development/examination – stakeholder workshops)

CR-102 – Notice of Proposed Rule Making (Approved rule language, official public comment period and notice of rules hearing.)

CR-103 – Rule making Order (Notice of adopted rules or notice of emergency rule adoption)

CR-105 – Expedited Rule Making due to the limited scope of a CR-105, there is no public hearing. A person may object to the use of the expedited rulemaking process within 45 days after the notice of proposed rulemaking is filed.

Inquiry Phase (CR-101)

Medication Assistance: WSR 22-02-015 (PDF)
Accessible Labeling Standards (Refiled June 12, 2023): WSR 23-13-035 (PDF)
Suspicious Orders and Zero Reports: WSR 23-10-012 (PDF)
Mobile Opioid Treatment Program Units: WSR 23-18-046 (PDF)
Transfer Practices (Brown and White Bagging): WSR 23-20-115 (PDF)
Uniform Facility Enforcement Framework: WSR 24-15-057 (PDF)
Permanent Facility Closure Requirements: WSR 24-13-061 (PDF)

Rule Proposed - Pending public rules hearing (CR-102)

Dialysate and Dialysis Device Manufacturers and Wholesalers: WSR 24-14-140 (PDF)
Prescription Transfer Requirement: WSR 24-17-002 (PDF)
Pharmacy Intern Registration: WSR 24-07-007 (PDF)
Drugs Stored Outside of the Pharmacy: WSR 24-17-006 (PDF)